# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001144204-18-053841
Filing Date
2018-10-15
Accepted
2018-10-15 16:44:17
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROSPECTUS | tv504787-424b4.htm | 424B4 | 291612
2 | GRAPHIC | lg_ampliphi.jpg | GRAPHIC | 42798
3 | GRAPHIC | tv501500_slide1.jpg | GRAPHIC | 476195
4 | GRAPHIC | tv501500_slide2.jpg | GRAPHIC | 387484
5 | GRAPHIC | tv501500_slide3.jpg | GRAPHIC | 330158
6 | GRAPHIC | tv501500_slide4.jpg | GRAPHIC | 495249
7 | GRAPHIC | tv501500_slide5.jpg | GRAPHIC | 662343
| Complete submission text file | 0001144204-18-053841.txt |  | 3465917

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-226959 | Film No.: 181122643
SIC: 2836 Biological Products, (No Diagnostic Substances)